Epidemiological studies of the association between tea drinking and primary liver cancer: A meta-analysis

European Journal of Cancer Prevention

Volumn 20, Issue 3, 2011, Pages 157-165

  Sing, Mélanie Fon ^a   Yang, Wan Shui ^b,c   Gao, Shan ^b,c   Gao, Jing ^b,c   Xiang, Yong Bing ^b,c  

^a UNIVERSITÉ LYON 1   (France)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

epidemiology; liver cancer; meta analysis; tea drinking

Indexed keywords

ARTICLE; CANCER PREVENTION; CANCER RISK; DIETARY INTAKE; HUMAN; LIVER CANCER; LIVER PROTECTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK REDUCTION; TEA;

BEVERAGES; CASE-CONTROL STUDIES; COHORT STUDIES; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; RISK FACTORS; SURVIVAL RATE; TEA; UNITED STATES;

EID: 79955068545     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3283447497     Document Type: Article

References (51)

1. Ahmad N, Mukhtar H (1999). Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr Rev 57:78-83. (Pubitemid 29176620)
2. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H (1997). Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 89:1881-1886. (Pubitemid 28009824)
3. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
4. Chen SD, Zhang GQ, Lian JH (1999). A case-control study of primary liver cancer in Guangdong province of China. Chin J Public Health 18:231-232.
5. Chuang SC, La Vecchia C, Boetta P (2009). Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 286:9-14.
6. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials 7:177-188. (Pubitemid 17189972)
7. Dorgan JF, Longcope C, Stephenson HE Jr, Falk RT, Miller R, Franz C, et al. (1997). Serum sex hormone levels are related to breast cancer risk in postmenopausal women. Environ Health Perspect 105:583-585. (Pubitemid 27246420)
8. Egger M, Smith GD, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634. (Pubitemid 27387172)
9. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010). GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC cancer base No. 10. Lyon, France: International Agency for Research on Cancer. Available from: http://globocan.iarc.fr.
10. Graham HN (1992). Green tea composition, consumption, and polyphenol chemistry. Prev Med 21:334-350.
11. Gupta S, Hussain T, Mukhtar H (2003). Molecular pathway for (-)-epigallocatechin- 3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 410:177-185. (Pubitemid 36268810)
12. Inoue M, Yoshimi I, Sobue T, Tsugane S (2005). Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 97:293-300. (Pubitemid 40310277)
13. Jin X, Zheng RH, Li YM (2008). Green tea consumption and liver disease: a systematic review. Liver Int 28:990-996. (Pubitemid 352044448)
14. Khan N, Mukhtar H (2007). Tea polyphenols for health promotion. Life Sci 81:519-533. (Pubitemid 47212236)
15. Larsson SC,Wolk A (2007). Overweight, obesity and risk of liver cancer: a metaanalysis of cohort studies. Br J Cancer 97:1005-1008. (Pubitemid 47519294)
16. Lee YC, Cohet C, Yang YC, Stayner L, Hashibe M, Straif K (2009). Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. Int J Epidemiol 38:1497-1511.
17. Lin Y, Kikuchi S, Tamakoshi A, Yagyu K, Obata Y, Kurosawa M, et al. (2008). Green tea consumption and the risk of pancreatic cancer in Japanese adults. Pancreas 37:25-30.
18. Mittal A, Pate M, Wylie R, Tollefsbol TO, Katiyar SK (2004). EGCG downregulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int J Oncol 24:703-710.
19. Montella M, Polesel J, La Vecchia C, Dal Maso L, Crispo A, Crovatto M, et al. (2007). Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer 120:1555-1559. (Pubitemid 46355393)
20. Mu LN, Zhou XF, Ding BG, Wang RH, Zhang ZF, Chen CW, et al. (2003a). A case-control study on drinking green tea and decreasing risk of cancers in the alimentary canal among cigarette smokers and alcohol drinkers. Chin J Epidemiol 24:192-195.
21. Mu LN, Zhou XF, Ding BG,Wang RH, Zhang ZF, Jiang QW, et al. (2003b). Study on the protective effect of green tea on gastric, liver and esophageal cancers. Chin J Prev Med 37:171-173.
22. Mukhtar H, Ahmad N (1999). Green tea in chemoprevention of cancer. Toxicol Sci 52:111-117. (Pubitemid 30017584)
23. Nagano J, Kono S, Preston DL, Mabuchi K (2001). A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes &Control 12:150-154.
24. Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K (2000). Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 13:49-54. (Pubitemid 32107344)
25. Parkin DM, Pisani P, Muñoz N, Ferlay J (1999). The global health burden of infection associated cancers. In: Newton R, Beral V,Weiss R, editors. Cancer surveys volume 33, infections and human cancer. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; pp. 5-33.
26. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin 55:74-108. (Pubitemid 40372904)
27. Platet N, Cathiard AM, Gleizes M, Garcia M (2004). Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51:55-67. (Pubitemid 38781751)
28. Sartippour MR, Shao ZM, Heber D, Beatty P, Zhang L, Liu C, et al. (2002). Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr 132:2307-2311. (Pubitemid 34851667)
29. Satoh K, Sakamoto Y, Ogata A, Nagai F, Mikuriya H, Numazawa M, et al. (2002). Inhibition of aromatase activity by green tea extract catechins and their endocrinological effects of oral administration in rats. Food Chem Toxicol 40:925-933. (Pubitemid 34626700)
30. Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD (2009). Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 3:353-367.
31. Shimazu T, Tsubono Y, Kuriyama S, Ohmori K, Koizumi Y, Nishino Y, et al. (2005). Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 116:150-154. (Pubitemid 40827769)
32. Sun CL, Yuan JM, Lee MJ, Yang CS, Gao YT, Ross RK, et al. (2002). Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenesis 23: 1497-1503. (Pubitemid 35012430)
33. Sun CL, Yuan JM, Koh WP, Yu MC (2006a). Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 27:1310-1315. (Pubitemid 43985405)
34. Sun CL, Yuan JM, Koh WP, Yu MC (2006b). Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 27:1301-1309. (Pubitemid 43985404)
35. Tanaka K, Tsuji I, Wakai K, Nagata C, Mizoue T, Inoue M, et al. (2008). Alcohol drinking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 38:816-838.
36. Tang BM, Bian JC,Wang QJ,Wang G,Wang QM, Huang CJ, et al. (2002). The case-control study for the risk factors of HCC in Luoyang. Modern Prev Med 29:723-725.
37. Tang N,Wu Y, Zhou B,Wang B, Yu R (2009). Green tea, black tea consumption and risk of lung cancer: a meta-analysis. Lung Cancer 65:274-283.
38. Thangapazham RL, Singh AK, Sharma A,Warren J, Gaddipati JP, Maheshwari RK (2007). Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 245:232-241. (Pubitemid 44959362)
39. Uesato S, Kitagawa Y, Kamishimoto M, Kumagai A, Hori H, Nagasawa H (2001). Inhibition of green tea catechins against the growth of cancerous human colon and hepatic epithelial cells. Cancer Lett 170:41-44. (Pubitemid 32607659)
40. Ui A, Kuriyama S, Kakizaki M, Sone T, Nakaya N, Ohmori-Matsuda K, et al. (2009). Green tea consumption and the risk of liver cancer in Japan: the Ohsaki cohort study. Cancer Causes Control 20:1939-1945.
41. Vergote D, Cren-Olivé C, Chopin V, Toillon RA, Rolando C, Hondermarck H, et al. (2002). Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts. Breast Cancer Res Treat 76:195-201. (Pubitemid 35335209)
42. Wang JY, Zhu L, Wu DL, Wang XS, Li DH, Zhang XF, et al. (2008a). Matched case-control study on factors for main cancer in a low incidence area of Jiangsu province. Chin J Cancer Prev Treat 15:565-568. (Pubitemid 351818498)
43. Wang N, Zheng Y, Jiang Q, Yu X, Chen Y (2008b). Tea and reduced liver cancer mortality. Epidemiology 19:761.
44. Weisburger JH (1999). Tea and health: the underlying mechanisms. Proc Soc Exp Biol Med 220:271-275. (Pubitemid 29153139)
45. Woolf B (1955). On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253.
46. Yang CS,Wang ZY (1993). Tea and cancer. J Natl Cancer Inst 85:1038-1049. (Pubitemid 23199184)
47. Yang CS, Wang X, Lu G, Picinich SC (2009). Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 81:519-533.
48. Yu XS, Huang PX, Qin J, Wang LP, Qian XF, Jiang JH, et al. (2006). A cohort study on risk factors of hepatocellular carcinoma in Haimen city. Chin Prev Med 7:241-243.
49. Yuan JM, Gao YT, Yang CS, Yu MC (2007). Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai cohort study. Intl J Cancer 120:1344-1350.
50. Zhou Y, Li N, Zhuang W, Liu G,Wu T, Yao X, et al. (2008). Green tea and gastric cancer risk: meta-analysis of epidemiologic studies. Asia Pac J Clin Nutr 17:159-165.
51. Zhou XH, Qiao Q, Zethelius B, PyöräläK, Söderberg S, Pajak A, et al. (2010). Diabetes, prediabetes and cancer mortality. Diabetologia 53:1867-1876.